Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Recce Pharmaceuticals Ltd. ( (AU:RCE) ) has issued an update.
Recce Pharmaceuticals Ltd has announced the quotation of 17,857,143 ordinary fully paid securities on the Australian Securities Exchange (ASX) under the code RCE. This move is part of previously announced transactions and may enhance the company’s financial flexibility and market presence, potentially impacting its operational capabilities and stakeholder interests positively.
More about Recce Pharmaceuticals Ltd.
Recce Pharmaceuticals Ltd is a company operating in the pharmaceutical industry, focusing on the development and commercialization of new classes of synthetic anti-infectives designed to address the urgent global health threat posed by antibiotic-resistant superbugs.
YTD Price Performance: -39.58%
Average Trading Volume: 210,969
Technical Sentiment Signal: Buy
Current Market Cap: A$68.9M
See more data about RCE stock on TipRanks’ Stock Analysis page.